Chris Martenson: Meeting the Covid Heros - Dr. Kory, Dr. Marik and Dr. Varon

By Peak Prosperity / January 07, 2021 / marketsanity.com / Article Link

For the best Covid information go to http://covid19criticalcare.com

Evie and I went to Houston on 1/3 to 1/6 and met up with the front line doctors behind the MATH+ and the iMASK protocols which they say are transforming Covid care and prevention. You know, the one that used the Drug Which Shall Not Be Named or DWSNBN2 (pronounced "dwizz-n-bin") These doctors are true heroes. They are putting their reputations, careers and tremendous personal energy on the line. They are tireless champions of doing what's best for their patients and they are driven to help many more. This is just a taste. Much longer videos are coming out soon as we shot many hours of interviews while there.

Christopher Martenson is a former American biochemical scientist. Currently he is a writer and trend forecaster interested in macro trends regarding the economy, energy composition and environment. He is the founder of PeakProsperity.com. As one of the early econobloggers who forecasted the housing market collapse and stock market correction years in advance, Chris rose to prominence with the launch of his seminal video seminar which later became a book called The Crash Course. Chris' latest book (co-authored with Adam Taggart) is called Prosper!: How to Prepare for the Future and Create a World Worth Inheriting.

Recent News

A shift to the later stages of gold and silver bull markets

October 27, 2025 / www.canadianminingreport.com

Gold stocks plunge on metal drop

October 27, 2025 / www.canadianminingreport.com

Gold stocks still up after pullback late in the week

October 20, 2025 / www.canadianminingreport.com

US regional bank slump goes global, driving market into gold

October 20, 2025 / www.canadianminingreport.com

Gold stocks weaker but outperform slump in other sectors

October 13, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok